Dementia with Lewy bodies (DLB) is a common neurodegenerative disorder in which patients exhibit symptoms of dementia and parkinsonism along with fluctuations and hallucinations that can be ...

That is, except one, which combined the drug with Aricept, a widely used drug already available on the market and used to treat Alzheimer's symptoms like memory loss and confusion. Together ...

As part of the regulatory action, memantine/donepezil extended-release capsules have been granted a 180-day exclusivity in ...

At this point, people may begin taking medications designed for early Alzheimer's disease. Options for earlier to middle stages include donepezil (Aricept), galantamine (Razadyne) and rivastigmine ...

NEW & IMPROVED: Aricept, only the second FDA-approved Alzheimer's drug, has fewer side effects than its predecessor. Aricept was developed by the Eisai Co. of Japan and is being sold in the United ...

BRIDGEWATER, N.J. - Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX), a pharmaceutical company with a market capitalization of ...

They tried memantine and Aricept, drugs for moderate to severe Alzheimer’s that can help with confusion and memory loss. Neither drug helped, and the side effects were intolerable. Today ...

There are four medications approved in the UK to ease a person’s dementia symptoms, including memory and thinking problems: donepezil rivastigmine galantamine memantine. These treatments are only ...

Many, including Alzheimer's disease, are treatable ... The FDA has since approved three drugs for the treatment of mild to moderate AD: Donepezil (Aricept) was approved in 1996, Rivastigmine (Exelon) ...